Feel30 review

Feel30 puts bloodwork into the testosterone pathway and publishes a clear sermorelin ladder: $229 month to month, $1,134 for six months or $1,788 for a year. Its rendered testosterone and enclomiphene pages show a $149 monthly starting headline, without the sermorelin plan cards as visible hormone offers. Precision Medicine and Triad Rx are now named as pharmacy partners, though neither is assigned to an individual prescription in public. Conflicting lab-charge, billing and refund statements still need a written answer before enrolling.

Feel30 is operated by F3 Health Inc, an Austin, Texas company founded in 2025. It is a concierge telehealth brand built around testosterone replacement rather than weight loss, offering weekly injectable testosterone cypionate, oral enclomiphene, sermorelin as an at-home injection, and the ED medications sildenafil and tadalafil. It describes same-day video access to a physician, a patient portal and a members club. Its clinical page names Anneliese Cadena, a board-certified AGNP-C, as a clinical consultant, alongside an unnamed medical advisory board. It shows a LegitScript seal. Testosterone therapy is listed in roughly 35 jurisdictions, with enclomiphene available nationwide.

Testosterone onboarding involves labs and medical evaluation, with a professional home draw or Quest/LabCorp option and quarterly follow-up bloodwork advertised. Sermorelin takes a lighter online route, with labs possible if a clinician orders them. Feel30 names Precision Medicine and Triad Rx as pharmacy partners and OpenLoop Healthcare Partners, PC, among affiliated medical organizations; it does not identify a patient-specific pharmacy, named MD/DO medical director or home-draw network. Its September 2026 terms say lab-only collection, processing or nurse fees may be nonrefundable after scheduling or performance, legacy bundled care may deduct $129 in an eligibility refund, and subscriptions have no partial-period refunds. An older returns page instead offers a full medical-ineligibility refund and asks for 72-hour subscription notice. Confirm the actual refund and billing terms in writing.

The visible sermorelin offers are $229 month to month, $189 monthly equivalent with $1,134 billed for six months, and $149 equivalent with $1,788 billed annually. The testosterone cypionate and enclomiphene pages show a $149 monthly starting headline. They do not visibly offer the sermorelin ladder, so selected hormone plan duration and first charge remain unknown. Product copy says labs are included, brand facts estimates about $99 for initial labs, and September 2026 terms mention a $129 legacy bloodwork deduction after ineligibility. Those statements do not establish one universal lab debit. Brand facts and the July 2025 returns page also differ on when the first subscription is charged.

Compounded where compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Feel30 names Precision Medicine and Triad Rx as pharmacy partners without assigning either to a patient, and compounded sterile products are not reviewed by FDA for purity and potency the way approved drugs are. The three products it sells sit on very different evidence. Testosterone cypionate is a long-established, FDA-approved drug with decades of human safety data behind it in men with diagnosed hypogonadism — the strongest evidence base of the therapies sold here — and with correspondingly real obligations: hematocrit, PSA and lipid monitoring, and suppression of sperm production that can persist after stopping. It is also DEA Schedule III, which brings prescribing rules the site does not discuss publicly. Enclomiphene is a different drug entirely and should not be read as a milder testosterone: it is a selective estrogen receptor modulator that raises endogenous testosterone by lifting LH and FSH, and unlike exogenous testosterone it generally preserves fertility. Sermorelin is the weakest of the three on evidence — a GHRH analog acting on a real, well-described growth-hormone axis, but with thin long-term human outcome data and no controlled trial demonstrating the body-composition, recovery or anti-aging results the category is sold on. Individual results vary.